Product
TDF
Aliases
TDF Placebo, Viread®
8 clinical trials
6 indications
Indication
Chronic Hepatitis BIndication
Hepatitis BIndication
ChronicIndication
Chronic Hepatitis B InfectionIndication
Chronic HBV InfectionsIndication
HIV InfectionsClinical trial
A Multi-center, Randomized, Blinded Study to Evaluate the Efficacy and Safety of Peginterferon Alfa-2b Injection Combined With Tenofovir Disoproxil Fumarate Tablets in Patients With Chronic Hepatitis BStatus: Completed, Estimated PCD: 2023-11-30
Clinical trial
A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Patients With Chronic Hepatitis B InfectionStatus: Active (not recruiting), Estimated PCD: 2017-08-07
Clinical trial
A Platform Study Evaluating the Efficacy and Safety of Investigational Therapies in Participants With Chronic Hepatitis B Infection (PREVAIL)Status: Active (not recruiting), Estimated PCD: 2026-03-01
Clinical trial
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD Versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis BStatus: Completed, Estimated PCD: 2015-09-30
Clinical trial
A Phase 3, Randomized, Multicenter, Double-blind, Double-dummy, Parallel-controlled Study to Evaluate the Safety and Efficacy of HS-10234 25 mg QD Versus TDF 300 mg QD for the Treatment of Patients With HBeAg+/- Chronic HBV Infection.Status: Active (not recruiting), Estimated PCD: 2020-05-31
Clinical trial
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD Versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Positive, Chronic Hepatitis BStatus: Completed, Estimated PCD: 2015-11-16
Clinical trial
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD Versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis BStatus: Completed, Estimated PCD: 2017-02-24
Clinical trial
Body Composition Sub-study of the D2EFT TrialStatus: Active (not recruiting), Estimated PCD: 2024-01-15